USE OF A LIQUID ALLERGY VACCINE FORMULATION FOR OROMUCOSAL ADMINISTRATION

The present invention relates to the use of an allergen for the manufacture of a liquid vaccine formulation for preventing or treating allergy in a subject by oromucosal administration in a dosage regimen comprising no up-dosing.

Saved in:
Bibliographic Details
Main Authors HERNANDEZ, DOMINGO BARBER, NIETO, PILAR RICO, MARTINEZ, FERNANDO DE LA TORRE
Format Patent
LanguageEnglish
French
Published 10.05.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the use of an allergen for the manufacture of a liquid vaccine formulation for preventing or treating allergy in a subject by oromucosal administration in a dosage regimen comprising no up-dosing.
Bibliography:Application Number: CA20062628226